1. Quan, Jing, Bode, Ann M, Luo, Xiangjian. 2021. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. In European journal of pharmacology, 909, 174397. doi:10.1016/j.ejphar.2021.174397. https://pubmed.ncbi.nlm.nih.gov/34332918/
2. Lai, Zhenyu, Li, Shipeng, Wu, Fei, Lei, Chuzhao, Dang, Ruihua. 2020. Genotypes and haplotype combination of ACSL3 gene sequence variants is associated with growth traits in Dezhou donkey. In Gene, 743, 144600. doi:10.1016/j.gene.2020.144600. https://pubmed.ncbi.nlm.nih.gov/32217139/
3. Tan, Shirong, Sun, Xiangyu, Dong, Haoran, Xu, Ling, Xu, Yingying. . ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis. In Cancer biology & medicine, 21, 606-35. doi:10.20892/j.issn.2095-3941.2023.0309. https://pubmed.ncbi.nlm.nih.gov/38953696/
4. Yuan, Hua, Li, Xuemei, Zhang, Xiuying, Kang, Rui, Tang, Daolin. 2016. Identification of ACSL4 as a biomarker and contributor of ferroptosis. In Biochemical and biophysical research communications, 478, 1338-43. doi:10.1016/j.bbrc.2016.08.124. https://pubmed.ncbi.nlm.nih.gov/27565726/
5. Migita, Toshiro, Takayama, Ken-Ichi, Urano, Tomohiko, Takahashi, Satoru, Inoue, Satoshi. 2017. ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells. In Cancer science, 108, 2011-2021. doi:10.1111/cas.13339. https://pubmed.ncbi.nlm.nih.gov/28771887/
6. Wang, Ziyi, Li, Hongyu, Cai, Hongshi, Hou, Chen, Hou, Jinsong. 2023. FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4. In International journal of molecular sciences, 24, . doi:10.3390/ijms242216339. https://pubmed.ncbi.nlm.nih.gov/38003537/
智鼠故事 
